Cold Preservation vs. Machine Perfusion for Liver Transplants
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Declined liver in Normothermic Machine Perfusion (NMP) for liver transplants?
Is normothermic machine perfusion (NMP) safe for liver transplants?
Normothermic machine perfusion (NMP) for liver transplants has been shown to be safe in clinical trials, with improved liver function compared to traditional cold storage methods. However, there are potential technical risks, and more extensive studies are needed to fully understand its safety profile.15678
How does the treatment of declined liver in normothermic machine perfusion differ from other treatments for liver transplants?
What is the purpose of this trial?
This is a prospective, non-randomized, clinical trial of discarded liver transplants that have received normothermic machine perfusion (NMP), compared with standard cold preservation liver transplants. The discarded livers rejected by all other centers and meeting pre-NMP eligibility criteria will receive NMP using the OrganOx® metra device. The NMP-treated liver that meets the viability criteria will be transplanted to patients who are eligible and consented to the study. Liver transplant outcomes will be ascertained during 12 months post-transplantation. The results of the trial will be compared with those of contemporary comparison groups of patients who received the standard criteria donor liver transplantation.
Research Team
Will Chapman, M.D.
Principal Investigator
Washington University School of Medicine
Eligibility Criteria
This trial is for adults with end-stage liver disease who are on the UNOS waiting list for a primary liver transplant. They must be able to walk over 350 meters in six minutes or have mild/no frailty. Donors' livers, which were declined by other centers and meet specific criteria including weight and ischemia times, will be used.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Transplantation of NMP-treated livers to eligible patients
Follow-up
Participants are monitored for safety and effectiveness after transplantation
Extended Follow-up
Long-term monitoring of liver graft function and patient survival
Treatment Details
Interventions
- Declined liver in Normothermic Machine Perfusion (NMP)
- Standard cold preservation of liver
Declined liver in Normothermic Machine Perfusion (NMP) is already approved in United States, European Union for the following indications:
- Liver transplantation for end-stage liver disease
- Liver transplantation for end-stage liver disease
Find a Clinic Near You
Who Is Running the Clinical Trial?
Washington University School of Medicine
Lead Sponsor
OrganOx Ltd.
Industry Sponsor
Mid-America Transplant
Collaborator